Inhaled Steroid Reduces Systemic Inflammation in COPD
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
Systemic inflammation is present in chronic obstructive pulmonary disease (COPD), which has
been linked to cardiovascular morbidity and mortality. We determined the effects of oral and
inhaled corticosteroids on serum markers of inflammation in patients with stable COPD.